CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $42,638 | -54.6% | 7,301 | -47.3% | 0.00% | – |
| Q3 2022 | $94,000 | +129.3% | 13,861 | +42.6% | 0.00% | – |
| Q2 2022 | $41,000 | -24.1% | 9,719 | -39.5% | 0.00% | – |
| Q1 2022 | $54,000 | -6.9% | 16,066 | -12.9% | 0.00% | – |
| Q4 2021 | $58,000 | -38.3% | 18,449 | -35.6% | 0.00% | – |
| Q3 2021 | $94,000 | -13.0% | 28,665 | +12.2% | 0.00% | – |
| Q2 2021 | $108,000 | -44.0% | 25,544 | -33.7% | 0.00% | – |
| Q1 2021 | $193,000 | -58.5% | 38,525 | +4.8% | 0.00% | – |
| Q4 2020 | $465,000 | +38.4% | 36,743 | +7.4% | 0.00% | – |
| Q3 2020 | $336,000 | -34.5% | 34,224 | -33.6% | 0.00% | – |
| Q2 2020 | $513,000 | -1.5% | 51,556 | -12.5% | 0.00% | – |
| Q1 2020 | $521,000 | -28.2% | 58,953 | -25.0% | 0.00% | – |
| Q4 2019 | $726,000 | +50.6% | 78,629 | -4.0% | 0.00% | – |
| Q3 2019 | $482,000 | -40.8% | 81,908 | +20.8% | 0.00% | – |
| Q2 2019 | $814,000 | +8.4% | 67,824 | +9.1% | 0.00% | – |
| Q1 2019 | $751,000 | -0.1% | 62,181 | +3.7% | 0.00% | – |
| Q4 2018 | $752,000 | -34.2% | 59,936 | -22.1% | 0.00% | – |
| Q3 2018 | $1,142,000 | -12.1% | 76,976 | -0.3% | 0.00% | -100.0% |
| Q2 2018 | $1,299,000 | -54.9% | 77,188 | -38.7% | 0.00% | 0.0% |
| Q1 2018 | $2,882,000 | -62.0% | 125,848 | -57.0% | 0.00% | -66.7% |
| Q4 2017 | $7,576,000 | +98.7% | 292,854 | +13.3% | 0.00% | +50.0% |
| Q3 2017 | $3,812,000 | +178.9% | 258,434 | +163.7% | 0.00% | +100.0% |
| Q2 2017 | $1,367,000 | -29.8% | 97,985 | -14.1% | 0.00% | 0.0% |
| Q1 2017 | $1,946,000 | +7.2% | 114,066 | -35.4% | 0.00% | 0.0% |
| Q4 2016 | $1,816,000 | -0.5% | 176,451 | -2.3% | 0.00% | 0.0% |
| Q3 2016 | $1,825,000 | -25.8% | 180,575 | -17.6% | 0.00% | -50.0% |
| Q2 2016 | $2,461,000 | -21.9% | 219,192 | -5.0% | 0.00% | 0.0% |
| Q1 2016 | $3,151,000 | -32.9% | 230,638 | -6.8% | 0.00% | -33.3% |
| Q4 2015 | $4,695,000 | -10.8% | 247,515 | -11.8% | 0.00% | -25.0% |
| Q3 2015 | $5,266,000 | +25.1% | 280,574 | -0.8% | 0.00% | +33.3% |
| Q2 2015 | $4,211,000 | -2.7% | 282,798 | -1.1% | 0.00% | 0.0% |
| Q1 2015 | $4,328,000 | +19.5% | 285,799 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $3,623,000 | – | 272,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |